(PESI) Perma-Fix Environmental Svcs - Overview
Stock: Waste Treatment, Radiological Services, Decontamination, Disposal
EPS (Earnings per Share)
Revenue
| Risk 5d forecast | |
|---|---|
| Volatility | 68.7% |
| Relative Tail Risk | -11.0% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | 0.92 |
| Alpha | 34.96 |
| Character TTM | |
|---|---|
| Beta | 1.003 |
| Beta Downside | 0.918 |
| Drawdowns 3y | |
|---|---|
| Max DD | 58.00% |
| CAGR/Max DD | 0.64 |
Description: PESI Perma-Fix Environmental Svcs January 01, 2026
Perma-Fix Environmental Services, Inc. (NASDAQ:PESI) operates two core segments in the U.S.: a Treatment segment that processes nuclear, low-level radioactive, mixed, hazardous and non-hazardous waste, and a Services segment that delivers radiological measurements, health-physics support, de-contamination & de-commissioning (D&D), and related engineering and consulting services to government, commercial and research customers.
In FY 2023 the company generated roughly $71 million in revenue, with the Services segment contributing about 60 % of that total, while the Treatment segment accounted for the remaining 40 %. The backlog of contracted work stood near $150 million, indicating a multi-year revenue runway that is heavily weighted toward long-term DOE and utility de-commissioning projects.
Key economic drivers for PESI include federal spending on nuclear waste management-DOE’s Office of Environmental Management budget grew 7 % YoY in 2023-and heightened ESG scrutiny that pushes utilities to outsource hazardous waste handling to specialized firms. The broader Environmental & Facilities Services sector is also benefitting from tighter hazardous-waste regulations and the anticipated expansion of nuclear power capacity in the United States.
For a deeper quantitative view, you might explore ValueRay’s analyst toolkit.
Piotroski VR‑10 (Strict, 0-10) 0.5
| Net Income: -11.6m TTM > 0 and > 6% of Revenue |
| FCF/TA: -0.17 > 0.02 and ΔFCF/TA -6.62 > 1.0 |
| NWC/Revenue: 30.32% < 20% (prev 14.04%; Δ 16.28% < -1%) |
| CFO/TA -0.13 > 3% & CFO -11.9m > Net Income -11.6m |
| Net Debt/EBITDA: error (EBITDA <= 0) |
| Current Ratio: 1.77 > 1.5 & < 3 |
| Outstanding Shares: last quarter (18.5m) vs 12m ago 16.89% < -2% |
| Gross Margin: 8.81% > 18% (prev 0.06%; Δ 875.1% > 0.5%) |
| Asset Turnover: 71.66% > 50% (prev 85.90%; Δ -14.24% > 0%) |
| Interest Coverage Ratio: -21.29 > 6 (EBITDA TTM -9.71m / Interest Expense TTM 539.0k) |
Altman Z'' -6.43
| A: 0.20 (Total Current Assets 42.3m - Total Current Liabilities 23.9m) / Total Assets 91.2m |
| B: -1.15 (Retained Earnings -105.1m / Total Assets 91.2m) |
| C: -0.14 (EBIT TTM -11.5m / Avg Total Assets 84.7m) |
| D: -2.94 (Book Value of Equity -105.2m / Total Liabilities 35.8m) |
| Altman-Z'' Score: -6.43 = D |
Beneish M -3.17
| DSRI: 1.40 (Receivables 20.3m/16.0m, Revenue 60.7m/67.1m) |
| GMI: 0.63 (GM 8.81% / 5.52%) |
| AQI: 0.89 (AQ_t 0.27 / AQ_t-1 0.31) |
| SGI: 0.90 (Revenue 60.7m / 67.1m) |
| TATA: 0.00 (NI -11.6m - CFO -11.9m) / TA 91.2m) |
| Beneish M-Score: -3.17 (Cap -4..+1) = AA |
What is the price of PESI shares?
Over the past week, the price has changed by +0.13%, over one month by +14.62%, over three months by +20.20% and over the past year by +52.14%.
Is PESI a buy, sell or hold?
- StrongBuy: 1
- Buy: 0
- Hold: 0
- Sell: 0
- StrongSell: 0
What are the forecasts/targets for the PESI price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 20 | 30.8% |
| Analysts Target Price | 20 | 30.8% |
| ValueRay Target Price | 19.9 | 30.4% |
PESI Fundamental Data Overview February 03, 2026
P/S = 4.6614
P/B = 5.1076
Revenue TTM = 60.7m USD
EBIT TTM = -11.5m USD
EBITDA TTM = -9.71m USD
Long Term Debt = 1.35m USD (from longTermDebt, last quarter)
Short Term Debt = 1.14m USD (from shortTermDebt, last quarter)
Debt = 4.12m USD (from shortLongTermDebtTotal, last quarter)
Net Debt = -12.3m USD (from netDebt column, last quarter)
Enterprise Value = 270.5m USD (282.8m + Debt 4.12m - CCE 16.4m)
Interest Coverage Ratio = -21.29 (Ebit TTM -11.5m / Interest Expense TTM 539.0k)
EV/FCF = -17.10x (Enterprise Value 270.5m / FCF TTM -15.8m)
FCF Yield = -5.85% (FCF TTM -15.8m / Enterprise Value 270.5m)
FCF Margin = -26.08% (FCF TTM -15.8m / Revenue TTM 60.7m)
Net Margin = -19.14% (Net Income TTM -11.6m / Revenue TTM 60.7m)
Gross Margin = 8.81% ((Revenue TTM 60.7m - Cost of Revenue TTM 55.3m) / Revenue TTM)
Gross Margin QoQ = 14.58% (prev 10.61%)
Tobins Q-Ratio = 2.97 (Enterprise Value 270.5m / Total Assets 91.2m)
Interest Expense / Debt = 2.82% (Interest Expense 116.0k / Debt 4.12m)
Taxrate = 21.0% (US default 21%)
NOPAT = -9.07m (EBIT -11.5m * (1 - 21.00%)) [loss with tax shield]
Current Ratio = 1.77 (Total Current Assets 42.3m / Total Current Liabilities 23.9m)
Debt / Equity = 0.07 (Debt 4.12m / totalStockholderEquity, last quarter 55.4m)
Debt / EBITDA = 1.27 (negative EBITDA) (Net Debt -12.3m / EBITDA -9.71m)
Debt / FCF = 0.78 (negative FCF - burning cash) (Net Debt -12.3m / FCF TTM -15.8m)
Total Stockholder Equity = 58.4m (last 4 quarters mean from totalStockholderEquity)
RoA = -13.72% (Net Income -11.6m / Total Assets 91.2m)
RoE = -19.87% (Net Income TTM -11.6m / Total Stockholder Equity 58.4m)
RoCE = -19.19% (EBIT -11.5m / Capital Employed (Equity 58.4m + L.T.Debt 1.35m))
RoIC = -14.97% (negative operating profit) (NOPAT -9.07m / Invested Capital 60.5m)
WACC = 9.50% (E(282.8m)/V(286.9m) * Re(9.61%) + D(4.12m)/V(286.9m) * Rd(2.82%) * (1-Tc(0.21)))
Discount Rate = 9.61% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: 100.0 | Cagr: 15.54%
Fair Price DCF = unknown (Cash Flow -15.8m)
EPS Correlation: -40.34 | EPS CAGR: -3.83% | SUE: 0.51 | # QB: 0
Revenue Correlation: -39.19 | Revenue CAGR: 0.52% | SUE: 0.59 | # QB: 0
EPS next Quarter (2026-03-31): EPS=-0.06 | Chg30d=-0.040 | Revisions Net=-1 | Analysts=1
EPS next Year (2026-12-31): EPS=0.33 | Chg30d=-0.140 | Revisions Net=-1 | Growth EPS=+163.5% | Growth Revenue=+62.5%